Skip to main content
. 2024 Feb 8;124(4):1141–1149. doi: 10.1007/s13760-024-02474-4

Table 2.

Patient comorbidities and procedural details

Variable N = 73
Comorbidities
 Hypertension 43 (58.9)
 Diabetes 20 (27.4)
 Hyperlipidaemia 18 (24.7)
 Chronic kidney disease 11 (15.1)
 Prior ischaemic stroke 8 (11)
 Hypothyroidism 6 (8.2)
Procedure
 Cerebral DSA ± intervention 31 (42.5)
 Coronary angiogram ± intervention 31 (42.5)
 Contrast CT 3 (4.1)
 Carotid stent 2 (2.7)
 Abdominal aortic aneurysm repair 1 (1.4)
 Bronchial artery stent 1 (1.4)
 Lower limb angiogram 1 (1.4)
 Nasopharyngeal tumour embolisation 1 (1.4)
 Renal artery angiogram 1 (1.4)
 Thoracic aortic aneurysm repair 1 (1.4)
Contrast volume, median (range) 150 (18–1150)
Contrast type
 Iodixanol 15 (20.5)
 Iopamidol 13 (17.8)
 Iohexol 12 (16.4)
 Ioversol 9 (12.3)
 Iopromide 8 (11)
 Iomeprol 5 (6.8)
 Iomeron 1 (1.4)
 Iobitridol 1 (1.4)
 Iothalamate 1 (1.4)
 Not reported 8 (11)